IDR 396.0
(0.51%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -1485.56 Billion IDR | -1474.91% |
2022 | -94.32 Billion IDR | -131.21% |
2021 | 302.27 Billion IDR | 1613.68% |
2020 | 17.63 Billion IDR | 11.0% |
2019 | 15.89 Billion IDR | -96.18% |
2018 | 415.89 Billion IDR | 27.27% |
2017 | 326.78 Billion IDR | 22.2% |
2016 | 267.41 Billion IDR | 7.46% |
2015 | 248.84 Billion IDR | 6.06% |
2014 | 234.62 Billion IDR | 9.36% |
2013 | 214.54 Billion IDR | 4.59% |
2012 | 205.13 Billion IDR | 19.43% |
2011 | 171.76 Billion IDR | 23.83% |
2010 | 138.71 Billion IDR | 121.92% |
2009 | 62.5 Billion IDR | 12.84% |
2008 | 55.39 Billion IDR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -102.73 Billion IDR | 92.15% |
2024 Q3 | -195.05 Billion IDR | -57.24% |
2024 Q2 | -124.04 Billion IDR | -20.75% |
2023 Q4 | -1308.19 Billion IDR | -740.71% |
2023 Q1 | 6.04 Billion IDR | -93.27% |
2023 FY | -1485.56 Billion IDR | -1474.91% |
2023 Q2 | -22.14 Billion IDR | -466.36% |
2023 Q3 | -155.6 Billion IDR | -602.69% |
2022 Q3 | 24.18 Billion IDR | 111.58% |
2022 FY | -94.32 Billion IDR | -131.21% |
2022 Q4 | 89.8 Billion IDR | 271.36% |
2022 Q2 | -208.89 Billion IDR | -8172.73% |
2022 Q1 | 2.58 Billion IDR | 663.63% |
2021 Q1 | 17.29 Billion IDR | 188.42% |
2021 Q4 | 338.85 Million IDR | -99.86% |
2021 FY | 302.27 Billion IDR | 1613.68% |
2021 Q3 | 244.33 Billion IDR | 506.2% |
2021 Q2 | 40.3 Billion IDR | 133.06% |
2020 Q1 | 26.16 Billion IDR | 147.96% |
2020 FY | 17.63 Billion IDR | 11.0% |
2020 Q2 | 22.41 Billion IDR | -14.34% |
2020 Q3 | -11.37 Billion IDR | -150.77% |
2020 Q4 | -19.55 Billion IDR | -71.91% |
2019 Q4 | -54.55 Billion IDR | -821.49% |
2019 Q1 | 20.63 Billion IDR | -89.18% |
2019 Q2 | 27.12 Billion IDR | 31.45% |
2019 Q3 | -5.92 Billion IDR | -121.83% |
2019 FY | 15.89 Billion IDR | -96.18% |
2018 Q4 | 190.6 Billion IDR | 84.53% |
2018 Q2 | 84.78 Billion IDR | 127.87% |
2018 Q1 | 37.2 Billion IDR | -72.4% |
2018 FY | 415.89 Billion IDR | 27.27% |
2018 Q3 | 103.29 Billion IDR | 21.83% |
2017 Q3 | 96.89 Billion IDR | 47.08% |
2017 Q4 | 134.81 Billion IDR | 39.14% |
2017 Q2 | 65.87 Billion IDR | 125.68% |
2017 Q1 | 29.19 Billion IDR | -68.81% |
2017 FY | 326.78 Billion IDR | 22.2% |
2016 Q2 | 51.6 Billion IDR | 22.89% |
2016 FY | 267.41 Billion IDR | 7.46% |
2016 Q4 | 93.58 Billion IDR | 16.65% |
2016 Q1 | 41.99 Billion IDR | -50.76% |
2016 Q3 | 80.23 Billion IDR | 55.48% |
2015 Q3 | 86.13 Billion IDR | 156.82% |
2015 FY | 248.84 Billion IDR | 6.06% |
2015 Q1 | 43.9 Billion IDR | -51.65% |
2015 Q2 | 33.54 Billion IDR | -23.61% |
2015 Q4 | 85.26 Billion IDR | -1.01% |
2014 Q4 | 90.8 Billion IDR | 23.96% |
2014 FY | 234.62 Billion IDR | 9.36% |
2014 Q1 | 23.36 Billion IDR | -74.9% |
2014 Q3 | 73.24 Billion IDR | 55.16% |
2014 Q2 | 47.2 Billion IDR | 102.02% |
2013 Q1 | 24.43 Billion IDR | -57.13% |
2013 Q3 | 78.67 Billion IDR | 329.21% |
2013 Q4 | 93.1 Billion IDR | 18.33% |
2013 FY | 214.54 Billion IDR | 4.59% |
2013 Q2 | 18.33 Billion IDR | -24.99% |
2012 Q3 | 64.3 Billion IDR | 20.54% |
2012 Q4 | 57 Billion IDR | -11.36% |
2012 Q1 | 30.48 Billion IDR | -40.62% |
2012 Q2 | 53.34 Billion IDR | 74.99% |
2012 FY | 205.13 Billion IDR | 19.43% |
2011 Q2 | 12.94 Billion IDR | -46.13% |
2011 Q3 | 83.46 Billion IDR | 544.97% |
2011 Q4 | 51.34 Billion IDR | -38.49% |
2011 FY | 171.76 Billion IDR | 23.83% |
2011 Q1 | 24.02 Billion IDR | 0.0% |
2010 FY | 138.71 Billion IDR | 121.92% |
2009 FY | 62.5 Billion IDR | 12.84% |
2008 FY | 55.39 Billion IDR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
PT Enseval Putera Megatrading Tbk. | 688.49 Billion IDR | 315.769% |
PT Itama Ranoraya Tbk | 5.19 Billion IDR | 28677.211% |
PT Millennium Pharmacon International Tbk | 33.08 Billion IDR | 4589.8% |
PT Soho Global Health Tbk | 371.34 Billion IDR | 500.054% |